Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation

<p>Abstract</p> <p>Background</p> <p>Successful pregnancy via <it>in vitro </it>fertilization (IVF) depends on the recovery of an adequate number of healthy oocytes and on blastocyst implantation following uterine transfer. Two hormones, LH and hCG, utilize...

Full description

Bibliographic Details
Main Authors: Chambers Anne E, Nayini Krishnaveni P, Mills Walter E, Lockwood Gillian M, Banerjee Subhasis
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Reproductive Biology and Endocrinology
Subjects:
Online Access:http://www.rbej.com/content/9/1/161
_version_ 1818584502210920448
author Chambers Anne E
Nayini Krishnaveni P
Mills Walter E
Lockwood Gillian M
Banerjee Subhasis
author_facet Chambers Anne E
Nayini Krishnaveni P
Mills Walter E
Lockwood Gillian M
Banerjee Subhasis
author_sort Chambers Anne E
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Successful pregnancy via <it>in vitro </it>fertilization (IVF) depends on the recovery of an adequate number of healthy oocytes and on blastocyst implantation following uterine transfer. Two hormones, LH and hCG, utilize a common LH/hCG receptor (LHCGR), variations in which have profound implications in human reproduction. Soluble LHCGR (sLHCGR) is released from experimental cell lines and placental explants and it can be detected in the follicular fluid and serum.</p> <p>Methods</p> <p>To evaluate the impact of circulating soluble LHCGR (sLHCGR) in fertility treatment, we measured sLHCGR and LH-sLHCGR complex in serum from women seeking IVF using specifically developed quantitative enzyme-linked immunosorbent assays (ELISA). Following an IVF cycle of treatment, patients were grouped according to oocyte yield into low (lower than or equal to 7 oocytes), intermediate (8-14 oocytes) and high (greater than or equal to 15 oocytes) responders and pregnancy outcome noted.</p> <p>Results</p> <p>Pre-treatment sLHCGR identified many women at risk of ovarian hyperstimulation. Low levels of sLHCGR were associated with pregnancy in both high and low responders but sLHCGR did not significantly affect the treatment outcome of intermediate responders. Low responders who failed to become pregnant had high levels of circulating sLHCGR bound to LH (LH-sLHCGR).</p> <p>Conclusions</p> <p>Pre-treatment measurement of sLHCGR could be used to tailor individual fertility treatment programs and improve outcomes by avoiding ovarian hyperstimulation and poor embryo implantation.</p>
first_indexed 2024-12-16T08:22:11Z
format Article
id doaj.art-5d4177629f2a49ed94ec7111964333f0
institution Directory Open Access Journal
issn 1477-7827
language English
last_indexed 2024-12-16T08:22:11Z
publishDate 2011-12-01
publisher BMC
record_format Article
series Reproductive Biology and Endocrinology
spelling doaj.art-5d4177629f2a49ed94ec7111964333f02022-12-21T22:38:05ZengBMCReproductive Biology and Endocrinology1477-78272011-12-019116110.1186/1477-7827-9-161Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantationChambers Anne ENayini Krishnaveni PMills Walter ELockwood Gillian MBanerjee Subhasis<p>Abstract</p> <p>Background</p> <p>Successful pregnancy via <it>in vitro </it>fertilization (IVF) depends on the recovery of an adequate number of healthy oocytes and on blastocyst implantation following uterine transfer. Two hormones, LH and hCG, utilize a common LH/hCG receptor (LHCGR), variations in which have profound implications in human reproduction. Soluble LHCGR (sLHCGR) is released from experimental cell lines and placental explants and it can be detected in the follicular fluid and serum.</p> <p>Methods</p> <p>To evaluate the impact of circulating soluble LHCGR (sLHCGR) in fertility treatment, we measured sLHCGR and LH-sLHCGR complex in serum from women seeking IVF using specifically developed quantitative enzyme-linked immunosorbent assays (ELISA). Following an IVF cycle of treatment, patients were grouped according to oocyte yield into low (lower than or equal to 7 oocytes), intermediate (8-14 oocytes) and high (greater than or equal to 15 oocytes) responders and pregnancy outcome noted.</p> <p>Results</p> <p>Pre-treatment sLHCGR identified many women at risk of ovarian hyperstimulation. Low levels of sLHCGR were associated with pregnancy in both high and low responders but sLHCGR did not significantly affect the treatment outcome of intermediate responders. Low responders who failed to become pregnant had high levels of circulating sLHCGR bound to LH (LH-sLHCGR).</p> <p>Conclusions</p> <p>Pre-treatment measurement of sLHCGR could be used to tailor individual fertility treatment programs and improve outcomes by avoiding ovarian hyperstimulation and poor embryo implantation.</p>http://www.rbej.com/content/9/1/161soluble LHCGRLH-LHCGRAMHFSHOHSSIVFPregnancy
spellingShingle Chambers Anne E
Nayini Krishnaveni P
Mills Walter E
Lockwood Gillian M
Banerjee Subhasis
Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
Reproductive Biology and Endocrinology
soluble LHCGR
LH-LHCGR
AMH
FSH
OHSS
IVF
Pregnancy
title Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
title_full Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
title_fullStr Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
title_full_unstemmed Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
title_short Circulating LH/hCG receptor (LHCGR) may identify pre-treatment IVF patients at risk of OHSS and poor implantation
title_sort circulating lh hcg receptor lhcgr may identify pre treatment ivf patients at risk of ohss and poor implantation
topic soluble LHCGR
LH-LHCGR
AMH
FSH
OHSS
IVF
Pregnancy
url http://www.rbej.com/content/9/1/161
work_keys_str_mv AT chambersannee circulatinglhhcgreceptorlhcgrmayidentifypretreatmentivfpatientsatriskofohssandpoorimplantation
AT nayinikrishnavenip circulatinglhhcgreceptorlhcgrmayidentifypretreatmentivfpatientsatriskofohssandpoorimplantation
AT millswaltere circulatinglhhcgreceptorlhcgrmayidentifypretreatmentivfpatientsatriskofohssandpoorimplantation
AT lockwoodgillianm circulatinglhhcgreceptorlhcgrmayidentifypretreatmentivfpatientsatriskofohssandpoorimplantation
AT banerjeesubhasis circulatinglhhcgreceptorlhcgrmayidentifypretreatmentivfpatientsatriskofohssandpoorimplantation